Literature DB >> 26983602

Adenosine kinase facilitated astrogliosis-induced cortical neuronal death in traumatic brain injury.

Wei Jin1, Wei Xu1, Jing Chen1, Xiaoxiao Zhang1, Lei Shi1, Chuancheng Ren2.   

Abstract

Adenosine kinase (ADK) plays a pivotal role in regulating brain function by regulating adenosine level, and ADK inhibition protects against neuronal damage in cerebral ischemia and epilepsy; however, the effects of ADK in traumatic brain injury (TBI) have not been investigated. For exploring its effects, we generated a blade-induced rat focal brain injury model. Western blot analysis, immunohistochemistry and immunofluorescent staining suggested that ADK was up-regulated after TBI, and it was temporally and spatially associated with astrogliosis. Terminal deoxynucleotidyl transferase-mediated biotinylated-dUTP nick-end labeling showed that neuronal apoptosis was paralleled with TBI-induced ADK up-regulation and astrogliosis. For further investigating the role of ADK in astrogliosis-induced neuronal death, primary cultured astrocytes and neurons were utilized, lipopolysaccharide (LPS) was employed to mediate astrogliosis, and condition medium (CM) of reactive astrocytes was used to treat neurons. The results showed that astrocytes increased iNOS expression and secreted pro-inflammatory cytokines after LPS treatment, and CM of reactive astrocytes resulted neuronal death. Additionally, ADK knock-down didn't ameliorate LPS-induced astrocyte proliferation, but it protected against neuronal death by reducing iNOS expression, tumor necrosis factor α and interleukin 1β secretion of reactive astrocytes. Taken together, ADK was associated with astrogliosis after TBI, its inhibition in reactive astrocytes ameliorated astrogliosis-induced neuronal death. Our findings extended the current knowledge on the role of ADK in astrogliosis, and also provided new evidence for the TBI treatment.

Entities:  

Keywords:  Adenosine kinase; Astrogliosis; Lipopolysaccharide; Neuron; Traumatic brain injury

Mesh:

Substances:

Year:  2016        PMID: 26983602     DOI: 10.1007/s10735-016-9670-7

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  37 in total

1.  Redox-sensitive protein phosphatase activity regulates the phosphorylation state of p38 protein kinase in primary astrocyte culture.

Authors:  K A Robinson; C A Stewart; Q N Pye; X Nguyen; L Kenney; S Salzman; R A Floyd; K Hensley
Journal:  J Neurosci Res       Date:  1999-03-15       Impact factor: 4.164

Review 2.  International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.

Authors:  Bertil B Fredholm; Adriaan P IJzerman; Kenneth A Jacobson; Joel Linden; Christa E Müller
Journal:  Pharmacol Rev       Date:  2011-02-08       Impact factor: 25.468

3.  Traumatic brain injury: from bench to bedside [corrected] to society.

Authors:  Anthony J-W Chen; Mark D'Esposito
Journal:  Neuron       Date:  2010-04-15       Impact factor: 17.173

4.  Blockade of A2A adenosine receptors prevents basic fibroblast growth factor-induced reactive astrogliosis in rat striatal primary astrocytes.

Authors:  Roberta Brambilla; Lorenzo Cottini; Marta Fumagalli; Stefania Ceruti; Maria P Abbracchio
Journal:  Glia       Date:  2003-08       Impact factor: 7.452

5.  Simvastatin attenuates microglial cells and astrocyte activation and decreases interleukin-1beta level after traumatic brain injury.

Authors:  Bo Li; Asim Mahmood; Dunyue Lu; Hongtao Wu; Ye Xiong; Changsheng Qu; Michael Chopp
Journal:  Neurosurgery       Date:  2009-07       Impact factor: 4.654

6.  A time course for the focal elevation of synthesis of basic fibroblast growth factor and one of its high-affinity receptors (flg) following a localized cortical brain injury.

Authors:  A Logan; S A Frautschy; A M Gonzalez; A Baird
Journal:  J Neurosci       Date:  1992-10       Impact factor: 6.167

Review 7.  Adenosine as a neuromodulator in neurological diseases.

Authors:  Detlev Boison
Journal:  Curr Opin Pharmacol       Date:  2007-10-17       Impact factor: 5.547

8.  Cyclic AMP response element modulator-1 (CREM-1) involves in neuronal apoptosis after traumatic brain injury.

Authors:  Xinmin Wu; Wei Jin; Xiaojuan Liu; Hongran Fu; Peipei Gong; Jian Xu; Gang Cui; Yaohui Ni; Kaifu Ke; Zhiwei Gao; Yilu Gao
Journal:  J Mol Neurosci       Date:  2012-05-09       Impact factor: 3.444

9.  Neuroglia at the crossroads of homoeostasis, metabolism and signalling: evolution of the concept.

Authors:  Vladimir Parpura; Alexei Verkhratsky
Journal:  ASN Neuro       Date:  2012-05-01       Impact factor: 4.146

10.  Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade.

Authors:  Rodrigo A Cunha
Journal:  Purinergic Signal       Date:  2005-03-17       Impact factor: 3.765

View more
  6 in total

Review 1.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

2.  Involvement of d-amino acid oxidase in cerebral ischaemia induced by transient occlusion of the middle cerebral artery in mice.

Authors:  Hao Liu; Meng-Jing Zhao; Zi-Ying Wang; Qiao-Qiao Han; Hai-Yun Wu; Xiao-Fang Mao; Yong-Xiang Wang
Journal:  Br J Pharmacol       Date:  2019-07-15       Impact factor: 8.739

3.  Follistatin-like protein 1 suppressed pro-inflammatory cytokines expression during neuroinflammation induced by lipopolysaccharide.

Authors:  Kai-Yuan Cheng; Yi Liu; Ying-Guang Han; Jing-Kun Li; Jia-Lin Jia; Bin Chen; Zhi-Xiao Yao; Lin Nie; Lei Cheng
Journal:  J Mol Histol       Date:  2016-12-02       Impact factor: 2.611

4.  Adenosine A3 receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury.

Authors:  Susan A Farr; Salvatore Cuzzocrea; Emanuela Esposito; Michela Campolo; Michael L Niehoff; Timothy M Doyle; Daniela Salvemini
Journal:  J Neuroinflammation       Date:  2020-11-12       Impact factor: 8.322

Review 5.  A Levee to the Flood: Pre-injury Neuroinflammation and Immune Stress Influence Traumatic Brain Injury Outcome.

Authors:  Samuel Houle; Olga N Kokiko-Cochran
Journal:  Front Aging Neurosci       Date:  2022-01-12       Impact factor: 5.750

6.  Chemotherapy-induced pain is promoted by enhanced spinal adenosine kinase levels through astrocyte-dependent mechanisms.

Authors:  Carrie Wahlman; Timothy M Doyle; Joshua W Little; Livio Luongo; Kali Janes; Zhoumou Chen; Emanuela Esposito; Dilip K Tosh; Salvatore Cuzzocrea; Kenneth A Jacobson; Daniela Salvemini
Journal:  Pain       Date:  2018-06       Impact factor: 7.926

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.